Richard White PhD, MA

Richard is a Director of Oxford PharmaGenesis. He brings expertise in the elicitation and communication of patient insights through advisory panels, PROs and real-world evidence, and has given invited presentations on these areas at international congresses (e.g. ISMPP and TIPPA). His extensive experience in Patient Engagement involves a wide range of activities in rare diseases, including stakeholder mapping and the development of patient value propositions. Richard has chaired discussions at World Orphan Drug Congress Europe, authored a white paper on orphan drugs and was recently interviewed for a Pharma Times feature in this area.